ClinConnect ClinConnect Logo
Search / Trial NCT06428721

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

Launched by WRIGHT STATE UNIVERSITY · May 20, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a procedure called Fractionated Laser Resurfacing (FLR) to see if it can help protect older adults from developing precancerous skin conditions known as actinic keratoses (AKs) and potentially prevent skin cancer. The focus is on individuals aged 60 and older who have at least five AKs on each of their forearms or wrists. The study will also explore whether taking photographs of the skin can help predict where these precancerous spots might appear in the future.

To participate, you need to be 60 years or older, have between five and ten AKs on your forearms or wrists (so they can be monitored easily), and have fair skin (skin types I or II). Participants should be able to understand the study's procedures and risks. This trial is currently recruiting volunteers, and if you join, you can expect to be monitored closely throughout the study. It’s important to know that there are some health conditions and recent treatments that could prevent you from being eligible, so discussing your health history with the study team is essential.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult Males and Females aged 60 and older
  • Have at least 5 AKs on each forearm/wrist, but no more than 10 to allow for easy monitoring
  • Skin type fair (Fitzpatrick I-II)
  • Females must be post-menopausal and not be on systemic hormone replacement therapy
  • Able to comprehend procedures and risks
  • Exclusion Criteria:
  • More than 10 AKs on an extremity
  • AKs that are large (2-3+, hyperkeratotic grade 3 lesions)
  • AKs that are very thick (\>3 mm)
  • Medical history of diabetes
  • History of poor wound healing or scarring
  • Large tattoos that can interfere with study
  • Other serious health issues and other skin diseases that could interfere with the study
  • Recent (within 1 year) field therapies such as efudex cream or PDT to forearms/wrists.
  • Planning to leave region in next 5 years
  • Subjects with allergies to xylocaine will be excluded if they need this topical anesthetic.

About Wright State University

Wright State University is a distinguished academic institution located in Dayton, Ohio, renowned for its commitment to advancing healthcare through innovative research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and contributing to the broader scientific community. With a multidisciplinary approach, Wright State University collaborates with healthcare professionals, researchers, and industry partners to ensure the integrity and efficacy of its trials, ultimately striving to translate research findings into actionable clinical practices.

Locations

Fairborn, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Jeffrey Travers, MD, PhD

Principal Investigator

Wright State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported